{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:05Z","timestamp":1786985045189,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Natural Science Foundation","doi-asserted-by":"crossref","award":["Y2080096"],"award-info":[{"award-number":["Y2080096"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007834","name":"Ningbo Natural Science Foundation","doi-asserted-by":"crossref","award":["2007A610063"],"award-info":[{"award-number":["2007A610063"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhejiang Province medical and Health Science Research Fund","award":["2007A172"],"award-info":[{"award-number":["2007A172"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.bbrc.2016.01.119","type":"journal-article","created":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T12:31:17Z","timestamp":1454329877000},"page":"233-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Inhibition of MAPK and NF-\u03baB signaling pathways alleviate carbon tetrachloride (CCl4)-induced liver fibrosis in Toll-like receptor 5 (TLR5) deficiency mice"],"prefix":"10.1016","volume":"471","author":[{"given":"Ming","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-dan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo-an","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-rong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2016.01.119_bib1","first-page":"1846","article-title":"Non-alcoholic fatty liver diseases","volume":"140","author":"Roeb","year":"2015","journal-title":"Dtsch. Med. Wochenschr"},{"key":"10.1016\/j.bbrc.2016.01.119_bib2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1159\/000439074","article-title":"Chronic liver diseases and liver cancer: an update in 2015","volume":"33","author":"Kudo","year":"2015","journal-title":"Dig. Dis."},{"key":"10.1016\/j.bbrc.2016.01.119_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/742931","article-title":"NADPH oxidases in chronic liver diseases","volume":"2014","author":"Jiang","year":"2014","journal-title":"Adv. Hepatol."},{"key":"10.1016\/j.bbrc.2016.01.119_bib4","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3736\/jcim20110617","article-title":"Comparative study on WHO western Pacific region and World Federation of Chinese Medicine Societies international standard terminologies on traditional medicine: syndrome differentiation of liver and gallbladder diseases","volume":"9","author":"Li","year":"2011","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"10.1016\/j.bbrc.2016.01.119_bib5","doi-asserted-by":"crossref","first-page":"e1518","DOI":"10.7717\/peerj.1518","article-title":"Orphan nuclear receptor NR4A2 inhibits hepatic stellate cell proliferation through MAPK pathway in liver fibrosis","volume":"3","author":"Chen","year":"2015","journal-title":"PeerJ"},{"key":"10.1016\/j.bbrc.2016.01.119_bib6","article-title":"Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography","author":"Imajo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2016.01.119_bib7","doi-asserted-by":"crossref","first-page":"15713","DOI":"10.1073\/pnas.1522163112","article-title":"BRD4 is a novel therapeutic target for liver fibrosis","volume":"112","author":"Ding","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.01.119_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4161\/adip.22929","article-title":"The TLR family protein RP105\/MD-1 complex: a new player in obesity and adipose tissue inflammation","volume":"2","author":"Nagai","year":"2013","journal-title":"Adipocyte"},{"key":"10.1016\/j.bbrc.2016.01.119_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2222\/jsv.54.145","article-title":"TLR family and viral infection","volume":"54","author":"Uematsu","year":"2004","journal-title":"Uirusu"},{"key":"10.1016\/j.bbrc.2016.01.119_bib10","doi-asserted-by":"crossref","first-page":"18038","DOI":"10.1038\/srep18038","article-title":"Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4\/MyD88\/NF-kappaB signaling pathway","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2016.01.119_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/598109","article-title":"TLRs, NF-kappaB, JNK, and liver regeneration","volume":"2010","author":"Iimuro","year":"2010","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.bbrc.2016.01.119_bib12","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.4049\/jimmunol.1303083","article-title":"Intestinal expression of fas and fas ligand is upregulated by bacterial signaling through TLR4 and TLR5, with activation of fas modulating intestinal TLR-mediated inflammation","volume":"193","author":"Fernandes","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2016.01.119_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nprot.2015.017","article-title":"High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers","volume":"10","author":"Mederacke","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbrc.2016.01.119_bib14","doi-asserted-by":"crossref","first-page":"e60115","DOI":"10.1371\/journal.pone.0060115","article-title":"Up-regulation of RACK1 by TGF-beta1 promotes hepatic fibrosis in mice","volume":"8","author":"Jia","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2016.01.119_bib15","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.febslet.2014.04.042","article-title":"Toll like receptor 2 knock-out attenuates carbon tetrachloride (CCl4)-induced liver fibrosis by downregulating MAPK and NF-kappaB signaling pathways","volume":"588","author":"Ji","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2016.01.119_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00108-009-2419-6","article-title":"Liver fibrosis \u2013 pathogenesis and novel therapeutic approaches","volume":"51","author":"Tacke","year":"2010","journal-title":"Internist (Berl)"},{"key":"10.1016\/j.bbrc.2016.01.119_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molmed.2010.01.006","article-title":"Proteomic approaches in the search for biomarkers of liver fibrosis","volume":"16","author":"Cowan","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbrc.2016.01.119_bib18","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1021\/pr101077c","article-title":"New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients","volume":"10","author":"Gangadharan","year":"2011","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.bbrc.2016.01.119_bib19","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.23795","article-title":"CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice","volume":"52","author":"Aoyama","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2016.01.119_bib20","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/jcmm.12293","article-title":"Overexpression of miR-483-5p\/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-beta stimulated HSCs in transgenic mice","volume":"18","author":"Li","year":"2014","journal-title":"J.\u00a0Cell Mol. Med."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1630119X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1630119X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T14:55:21Z","timestamp":1600095321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X1630119X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0006291X1630119X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.01.119","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of MAPK and NF-\u03baB signaling pathways alleviate carbon tetrachloride (CCl4)-induced liver fibrosis in Toll-like receptor 5 (TLR5) deficiency mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.01.119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}